IGF1 and infection: The addition of L-NAME to IGF1 treatment, however, reversed the phenotype of IGF1-associated infection resistance (IGF1+L-NAME vs IGF1: prevalence p = 0.05, intensity p = 0.003), resulting in prevalence of infection (Figure 5A) and mean oocysts per midgut (Figure 5B) in L-NAME+IGF1 treated mosquitoes that were not significantly different from control (IGF1+L-NAME vs control: prevalence p = 0.12, intensity p = 0.38).